The Cancer Letter

The Cancer Letter is a highly regarded weekly magazine that focuses on topics related to cancer research, drug development, legislative matters, and health care policies. It made its debut on December 21, 1973, and has since received numerous awards for its insightful coverage.

International, Trade/B2B

English

Newsletter (Print)

Outlet metrics

Domain Authority

Ranking

Global

#1038198

United States

#336484

Health/Health Conditions and Concerns

#953

Traffic sources

Monthly visitors

Articles

Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor? - The Cancer Letter

Oct 4, 2024 | cancerletter.com

Every summer since 2010, ten undergraduate students from diverse backgrounds get the opportunity to explore any curiosities they might have about careers in medicine at Memorial Sloan Kettering Cancer Center. The eight-week summer internship called the Summer Clinical Oncology Research Experience (SCORE) was started by former faculty member Laura Liberman and intended to give undergraduates […]
Tumors are able to form with no DNA mutations, fly study shows - The Cancer Letter

Sep 15, 2024 | cancerletter.com

Tumors are able to form without any DNA mutations, according to a recent proof-of-principle study performed in flies. Epigenetic changes alone—even temporary alterations—induced permanent cancer cell fate. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site […]
Solving problems doctors can’t fix: How Georgetown’s medical-legal partnership saves lives by including lawyers on cancer care teams Why every cancer center needs a Cancer LAW Project - The Cancer Letter

Aug 2, 2024 | cancerletter.com

By the end of 2022, Toni Monteiro had no fight left in her. She had been battling a rare blood cancer for three years. Her husband had just died. She was at risk of being evicted from her Washington, DC, apartment. Also, her heart was failing. “You’re really under stress,” Monteiro recalls her physician saying. […]
60 years of ASCO annual meetings

May 31, 2024 | cancerletter.com | Paul Goldberg

As over 40,000 oncology professionals descend on Chicago’s McCormick Place yet again for the 60th American Society of Clinical Oncology annual meeting, we invite you to look back at The Cancer Letter and the Cancer History Project’s past coverage of the event.
ACS celebrates Black leaders whose contributions shaped health equity in cancer

Apr 5, 2024 | cancerletter.com | Wayne Frederick

In an article for the Cancer History Project, the American Cancer Society and the American Cancer Society Cancer Action Network celebrate six trailblazing Black leaders and pioneers who have made a lasting impact on health equity in oncology. Black Leaders Who Changed the Face of Equitable Cancer CareBy American Cancer Society, April 4, 2024Everyone deserves a fair and just opportunity to prevent, detect, treat, and survive cancer.
Kathy Giusti’s “Fatal to Fearless” memoir tells the story of prevailing over multiple myeloma

Mar 8, 2024 | cancerletter.com | Paul Goldberg

Sometimes in oncology, you get “beat-the-reaper” stories. To access this subscriber-only content please log in or renew your subscription. Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Radiation oncologist, global health expert C. Norman Coleman dies of sarcoma at 79

Mar 8, 2024 | cancerletter.com | Paul Goldberg

In September, Norm Coleman received great news: he qualified for the Ironman 70.3 World Championship in New Zealand. It’s a 70.3-mile race influenced by weather conditions and terrain: you swim 1.2 miles, bike another 56, and run 13.1 more. Norm, a guy about to hit 80, was beating the times of other super-athletes half his age. “Probably aren’t 20 people in the world that can still do that—doing fine,” Norm said, speaking with Otis Brawley and me on Jan.
Women’s History Month: Women who shaped oncology

Mar 8, 2024 | cancerletter.com | Paul Goldberg

This Women’s History Month, the Cancer History Project is documenting the lives of women who have shaped oncology.
Rutgers Cancer Institute redesignated as NCI Comprehensive Cancer Center

Mar 8, 2024 | cancerletter.com | Paul Goldberg

Rutgers Cancer Institute of New Jersey, together with RWJBarnabas Health, the state’s only NCI-designated Comprehensive Cancer Center, was redesignated by NCI. To access this subscriber-only content please log in or renew your subscription. Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Phase III Blenrep trial in multiple myeloma produces positive topline results

Mar 8, 2024 | cancerletter.com | Paul Goldberg

An interim analysis of the DREAMM-8 phase III head-to-head trial evaluating Blenrep (belantamab mafodotin), in combination with pomalidomide plus dexamethasone (PomDex), versus a standard of care, bortezomib plus PomDex, as a second line and later treatment for relapsed or refractory multiple myeloma, showed that the trial met its primary endpoint of progression-free survival at a prespecified interim analysis and was unblinded early based on the recommendation by an Independent Data...